Advances in Leica Biosystems Aperio VERSA* Digital Pathology for Cancer Researchers Showcased at AACR 2017

News provided by

Leica Biosystems

Mar 28, 2017, 09:00 ET

VISTA, Calfornia, March 28, 2017 /PRNewswire/ --

Leica Biosystems announced today that it will demonstrate cutting- edge technology, the Aperio VERSA digital pathology system, at the American Association of Cancer Researchers' meeting in Washington, DC April 1 - 5, 2017.

The Aperio VERSA is a comprehensive digital pathology scanner, designed and developed to support the diverse imaging needs of cutting edge research facilities. The combination scanner is optimized for precision scanning of brightfield and fluorescent samples, with the accuracy and resolution required for FISH. From tissue-based and proteomic markers, to subcellular, molecular and in-situ hybridization probes, the Aperio VERSA delivers high-resolution, reliable imaging. For Research Use Only. Not for use in diagnostic procedures. (PRNewsFoto/Leica Biosystems)

     (Photo: http://mma.prnewswire.com/media/483194/Leica_Biosystems.jpg )

Designed for the most demanding research facilities, Aperio VERSA incorporates brightfield and fluorescent whole slide imaging within a single system.  This state-of the-art scanner provides optimal resolution for investigation across a wide range of use cases, from tissue-based and proteomic markers, to subcellular, molecular and in-situ hybridization probes.

"Complex research underpins innovation in treatments to overcome disease," said Marlon Thompson, Vice President, Image Analysis and Clinical Solutions, for Leica Biosystems Pathology Imaging Business. "Aperio VERSA is a comprehensive and versatile digital pathology scanner with superior image quality and resolution. Aperio VERSA brings the power and usability required to deliver results."

"Leica Biosystems is also proud to present the latest evolution of the Aperio VERSA system - the automated oiler," stated Matthew Gorton, Product Manager, Pathology Systems,
Leica Biosystems Pathology Imaging Business. "With this release, we are extending the capabilities of the Aperio VERSA system to include a robust automated slide oiler which gives more options to the cancer research community. Aperio VERSA core design principles are flexibility, image quality and ease-of-use which our customers find so important."

Aperio VERSA, is a valuable tool for researchers. Visit booth #2831 for a live, educational, and hands-on experience or go to LeicaBiosystems.com/AACR2017 for more information.

*About Aperio Digital Pathology Solutions
Aperio VERSA: For Research Use Only. Not for use in diagnostic procedures.

About Leica Biosystems
Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.

SOURCE Leica Biosystems